FDAnews
www.fdanews.com/articles/101522-artec-to-test-tubercin-in-south-africa

Artec to Test Tubercin in South Africa

November 28, 2007

Artec has received the final plan to study Tubercin, a polysaccharide compound used as an immunostimulant, in HIV and tuberculosis patients in South Africa.

The company will reveal more details shortly and expects to begin treatment in early 2008.

Artec also is planning to use a product based on Tubercin in patients at wellness centers in the Bahamas in 2008, the company said.